Deafness Agency Locks Doors: Public Wondering What's Inside
Published Date: 12/19/2025
Notice
Summary
The National Institute on Deafness and Other Communication Disorders is holding a closed virtual meeting on March 23, 2026, to finish reviewing grant applications they couldn’t complete in January. This affects researchers waiting on funding decisions for projects about hearing and communication. No public attendance is allowed, but written comments can be sent in beforehand.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Closed NIH Grant Review Meeting
The National Institute on Deafness and Other Communication Disorders will hold a closed virtual meeting on March 23, 2026, from 9:00 a.m. to 12:00 p.m. to review and evaluate grant applications not finished at the January 22, 2026 meeting. The meeting is closed to public attendance, but written comments may be filed in advance with the contact person listed in the notice (Rebecca Miller, Ph.D.). This affects researchers waiting on funding decisions for projects about hearing and communication.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13612 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review and decide on important health research grant applications. These meetings keep sensitive info private to protect personal and commercial secrets. Researchers applying for grants and the public can expect no changes in funding timing or amounts, just careful, confidential reviews.
2026-13479 — Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute has created a new vaccine to stop HTLV-1, a virus that can cause serious diseases like leukemia. Right now, no vaccine exists, so this invention could protect millions, especially in underserved areas. They’re looking for partners to help develop and license this promising vaccine, which could save lives and reduce healthcare costs in the near future.
2026-13480 — Government Owned Invention Available for License: A Conserved Viral Peptide for Use in Cancer Immunotherapy
The National Cancer Institute has created a special viral peptide that could help prevent and treat a serious liver cancer called HCC. This new discovery might lead to a vaccine or therapy that boosts the immune system to fight cancer better. Researchers and companies interested in developing this treatment can now license the technology, opening doors for faster progress and potential health benefits worldwide.
2026-13337 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on July 24, 2026, to review and evaluate important grant applications related to cancer, imaging, eye diseases, and reproductive health. These meetings protect private info and trade secrets, so they’re not open to the public. Researchers and organizations applying for grants should note the dates as these reviews impact funding decisions.
2026-13311 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late July 2026 to review grant applications and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants or contracts should watch these dates closely, as funding decisions could impact their projects and budgets.
2026-13244 — The Federal Demonstration Partnership; Phase VIII Notice
The Federal Demonstration Partnership (FDP) is inviting colleges, universities, research groups, and hospitals that get federal research money to join its Phase VIII starting in 2027. This phase will keep testing new ways to make research funding and rules easier and faster. Applications are due by September 15, 2026, with the program running through the end of 2032.
Previous / Next Documents
Previous: 2025-23322 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on January 22, 2026, to review important grant applications in bioengineering, surgery, anesthesiology, and trauma. These meetings are private to protect secret ideas and personal info, ensuring fair and secure funding decisions. Researchers and institutions applying for grants should note this date as it impacts how their proposals are evaluated.
Next: 2025-23324 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding a closed virtual meeting on February 3, 2026, to review important drug development grant applications. This meeting is private to protect secret research info and personal details of applicants. Scientists and researchers applying for grants should note this date, but no new costs or changes affect the public.